PDCD1 and lung cancer: In three syngeneic models of lung cancer (LLC, 393P and Lacun3), our group demonstrated that short-term starvation enhances anticancer immunosurveillance to facilitate the therapeutic activity of PD-1/PD-L1 blockade [1].